Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-23-003810
Filing Date
2023-09-07
Accepted
2023-09-07 12:44:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 20390
  Complete submission text file 0001959173-23-003810.txt   21999
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Subject) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40097 | Film No.: 231241623
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065
Business Address
Kelly Jason R (Reporting) CIK: 0001845677 (see all company filings)

Type: 144